Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C

被引：0
作者：
Toniutto, P
Falleti, E
Caldato, M
Fontanini, E
Rossi, E
Fumagalli, S
Bitetto, D
Smirne, C
Minisini, R
Fabris, C
Pirisi, M
机构：
[1] Univ Eastern Piedmont, Udine, Italy
[2] Univ Udine, I-33100 Udine, Italy
[3] Univ Eastern Piedmont Amedeo Avogadro, Novara, Italy
来源：
HEPATOLOGY | 2005年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：479A / 480A
页数：2
相关论文
共 50 条
  • [21] Association of Genetic Variants With Rapid Fibrosis: Progression After Liver Transplantation for Hepatitis C
    Layden, Jennifer E.
    Tayo, Bamidele O.
    Cotler, Scott J.
    Clark, Nina M.
    Baraoidan, Kristine
    Friedman, Scott L.
    Cooper, Richard S.
    TRANSPLANTATION, 2014, 97 (10) : 1072 - 1078
  • [22] Angiotensin Blockade Does Not Affect Fibrosis Progression in Recurrent Hepatitis C After Liver Transplantation
    Guillaud, O.
    Gurram, K. C.
    Puglia, M.
    Lilly, L.
    Adeyi, O.
    Renner, E. L.
    Selzner, N.
    TRANSPLANTATION PROCEEDINGS, 2013, 45 (06) : 2331 - 2336
  • [23] A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation
    Yilmaz, Nevin
    Shiffman, Mitchell L.
    Stravitz, R. Todd
    Sterling, Richard K.
    Luketic, Velimir A.
    Sanyal, Arun J.
    Mills, A. Scott
    Contos, Melissa J.
    Coterell, Adrian
    Maluf, Daniel
    Posner, Marc P.
    Fisher, Robert A.
    LIVER TRANSPLANTATION, 2007, 13 (07) : 975 - 983
  • [24] SIROLIMUS DECREASES FIBROSIS PROGRESSION IN RECURRENT HEPATITIS C DISEASE POST-LIVER TRANSPLANTATION
    Tsunoda, Shirley
    Sarubbi, Christina
    Ho, Anh-Thu T.
    Hollenbach, Kathryn
    Chatfield, Eileen
    Khanna, Ajai
    Barry, Christopher T.
    Hart, Marquis E.
    Hassanein, Tarek
    HEPATOLOGY, 2009, 50 (04) : 590A - 590A
  • [25] Successful antiviral therapy for recurrent hepatitis C after liver transplantation stops progression of fibrosis
    Selzner, Nazia
    Adeyi, Oyedele
    Lilly, Leslie
    Herath, Chaturika
    Gurrarn, Krishna
    Therapondos, George
    Kashfi, Arash
    McGilvray, Fail
    Greig, Paul
    Cattral, Mark
    Selznerl, Markus
    Guindi, Maha
    Grant, David
    Levy, Gary
    Renner, Eberhard L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 609 - 609
  • [26] Result of Everolimus Treatment on Fibrosis Progression in Maintenance Liver Transplant Patients with Recurrent Hepatitis C
    Villamil, F.
    Gadano, A.
    Zingale, F.
    Perez, R.
    Gil, O.
    Yantorno, S.
    Mastai, R.
    Otero, A.
    Dong, G.
    Lopez, P.
    TRANSPLANTATION, 2012, 94 (10) : 9 - 9
  • [27] Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation
    Rigamonti, C.
    Donato, M. F.
    Fraquelli, M.
    Agnelli, F.
    Ronchi, G.
    Casazza, G.
    Rossi, G.
    Colombo, M.
    GUT, 2008, 57 (06) : 821 - 827
  • [28] Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C
    Toniutto, Pierluigi
    Fabris, Carlo
    Falleti, Edmondo
    Cussigh, Annarosa
    Fontanini, Elisabetta
    Bitetto, Davide
    Fornasiere, Ezio
    Minisini, Rosalba
    De Feo, Tullia
    Marangoni, Francesca
    Pirisi, Mario
    LIVER INTERNATIONAL, 2008, 28 (02) : 257 - 263
  • [29] Interleukin-10 promoter polymorphisms and liver fibrosis progression in patients with chronic hepatitis C in Japan
    Hamada, H
    Yatsuhashi, H
    Yano, K
    Arisawa, K
    Nakao, K
    Yano, M
    JOURNAL OF HEPATOLOGY, 2003, 39 (03) : 457 - 458
  • [30] Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression
    Lionetti, Raffaella
    Tisone, Giuseppe
    Palmieri, Giampiero
    Almerighi, Cristiana
    Anselmo, Alessandra
    Tariciotti, Laura
    Lenci, Ilaria
    De Luca, Linda
    Monaco, Andrea
    Angelico, Mario
    DIGESTIVE AND LIVER DISEASE, 2010, 42 (04) : 297 - 303
12345